JAVIER
SASTRE VALERA
Profesor asociado de Ciencias de la Salud
Hospital Universitario Son Espases
Palma, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Son Espases (11)
2023
2022
-
Correction to: SEOM‑GEMCAD‑TTD clinical guidelines for localized rectal cancer (2021) (Clinical and Translational Oncology, (2022), 24, 4, (646-657), 10.1007/s12094-022-02816-9)
Clinical and Translational Oncology
-
SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2021)
Clinical and Translational Oncology, Vol. 24, Núm. 4, pp. 646-657
2021
2019
-
Treatment and outcome of patients with stage is testicular cancer: A retrospective study from the Spanish germ cell cancer group
Journal of Urology, Vol. 202, Núm. 4, pp. 742-747
2017
-
Consensus Recommendations from the Spanish Germ Cell Cancer Group on the Use of High-dose Chemotherapy in Germ Cell Cancer
European Urology Focus, Vol. 3, Núm. 2-3, pp. 280-286
2015
-
Pazopanib in pretreated advanced neuroendocrine tumors: A phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE)
Annals of Oncology, Vol. 26, Núm. 9, pp. 1987-1993
2014
-
Prognostic factors for relapse in stage I seminoma: A new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG)
Annals of Oncology, Vol. 25, Núm. 11, pp. 2173-2178
-
Synchronous versus metachronous brain metastasis from testicular germ cell tumors (TGCT): an analysis from the Spanish Germ Cell Cancer Group data base
Clinical and Translational Oncology, Vol. 16, Núm. 11, pp. 959-965
2011
-
Risk-adapted treatment in clinical stage I testicular seminoma: The third Spanish Germ Cell Cancer Group study
Journal of Clinical Oncology, Vol. 29, Núm. 35, pp. 4677-4681
2003
-
Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma
Annals of Oncology, Vol. 14, Núm. 6, pp. 867-872